Author Question: Which patient(s) with cancer will require more intense monitoring when starting imatinib therapy? ... (Read 62 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
Which patient(s) with cancer will require more intense monitoring when starting imatinib therapy? You may select more than one answer.
 
  1. An obese patient
  2. A patient who cannot tolerate interferon
  3. A patient on warfarin for a history of thrombosis
  4. A patient with an allergic response to aspirin
  5. A patient taking carbamazepine for bipolar disorder

Question 2

While counseling a patient about bexarotene, the nurse should include which information?
 
  1. There is an increased risk of clotting.
  2. There is a need to monitor for lipid abnormalities.
  3. There is a need to take vitamin A supplements with this agent.
  4. It is important to avoid exertional activities.



234sdffa

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

Correct Answers: 3, 5

Answer to Question 2

Correct Answer: 2



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

For a complete list of videos, visit our video library